Effect of High-Density Lipoprotein Cholesterol Levels on Overall Survival and Major Adverse Cardiovascular and Cerebrovascular Events
- 1 May 2021
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 146, 8-14
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Anti‐oxidant properties of high‐density lipoprotein and atherosclerosisClinical and Experimental Pharmacology and Physiology, 2010
- Anti‐atherogenic effects of high‐density lipoprotein on nitric oxide synthesis in the endotheliumClinical and Experimental Pharmacology and Physiology, 2010
- High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular RiskJACC, 2008
- Formation of Dysfunctional High-Density Lipoprotein by MyeloperoxidaseTrends in Cardiovascular Medicine, 2005
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion systemAtherosclerosis, 1996
- Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.Journal of Clinical Investigation, 1995
- A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.Journal of Clinical Investigation, 1993
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989